Insights on Verdi's goal to help physicians build the best medical oncology practices.
2018/2019 Oncology Drug FDA Approvals Notifications Implications for Early Phase Clinical Trials Dr. Wael Harb & Wes Chapman *Originally published on 8/25/2019 by mwestonchapman.com Illustration of an immune system T cell killing a cancer cell Complete Response (kum-PLEET reh-SPONTS)…Read Full
NASHVILLE, Tenn., Aug. 6, 2019 — Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has launched Verdi Cancer and Research Center of Texas. The center, led by Dr. Jivesh Sharma and Dr. Amy Cripps, will provide…Read Full
FOR IMMEDIATE RELEASE Verdi Oncology, Inc. Completes Partnership with Nashville Oncology Associates, PC Nashville, Tennessee, July 1, 2019 – Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has partnered with Nashville Oncology Associates PC…Read Full
In order to be approved by the U.S. Food and Drug Association (FDA), potential new cancer therapies and drugs must go through clinical trials. Products awaiting approval can be anywhere from brand-new therapies to small additions to already-existing drugs. Public…Read Full
While clinical trials are extremely important to study all types of medicine, clinical trials for oncology are particularly important as they help researchers advance new treatment options. During a clinical trial, participants volunteer to try new drugs or treatments so…Read Full
As an oncology provider, the term value-based healthcare is often used in discussions regarding payment and patient care. But what exactly does value-based care mean? Let’s unpack some of the key pieces of this framework. Quality Versus Quantity Value-based…Read Full